I am a neurosurgeon and laboratory investigator who specializes in the treatment of patients with primary brain tumors and metastatic brain tumors, with career experience in the computational analysis and molecular profiling of human and mouse tumors for translational research. I am a member of the Brain Tumor Center and the Human Oncology and Pathogenesis Program. In the laboratory, my research focuses on the genomic analysis of human and mouse gliomas and medulloblastomas.
I have identified several new gene fusions affecting receptor tyrosine kinases in glioma and recently have used combined genomics and proteomics to characterize molecular subclasses of glioblastoma that feature distinct patterns of activation among signaling pathways. As a funded co-investigator and external co-chair in The Cancer Genome Atlas pilot project, I developed microarray and computational methods to identify candidate translocations and gene fusions from microarray data.
- Clinical Expertise: Brain Tumor Surgery; Neuroendoscopy; Stereotactic Surgery; Radiosurgery; Gamma Knife; Intraoperative Tumor Imaging; Functional MRI
- Languages Spoken: English
- Education: MD, Cornell University Medical College
- Residencies: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center; Dana Farber Cancer Institute/Harvard Medical School
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more